Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T Meadows

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
Cancer|December 15, 1980
Bone sarcoma as a second malignant neoplasm in children: influence of radiation and genetic predisposition for the Late Effects Study GroupA T Meadows, L C Strong, F P Li, et al.
The New England Journal of Medicine|March 10, 1983
Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)J R Anderson, J F Wilson, D T Jenkin, et al.
Medical and Pediatric Oncology|January 1, 1994
Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552J L Finlay, J R Anderson, A J Cecalupo, et al.
Medical and Pediatric Oncology|December 18, 2001
Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer GroupR Sposto, A T Meadows, R R Chilcote, et al.
Journal of Health Psychology|October 25, 2011
Pathways Linking Treatment Intensity and Psychosocial Outcomes among Adult Survivors of Childhood LeukemiaE Chen, L K Zeltzer, P M Bentler, et al.
Journal of the National Cancer Institute|March 1, 1987
Leukemia after therapy with alkylating agents for childhood cancerM A Tucker, A T Meadows, J D Boice, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912N L Kobrinsky, R Sposto, N R Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer GroupJ R Anderson, R D Jenkin, J F Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Childrens Cancer Study GroupA T Meadows, R Sposto, R D Jenkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1984
The treatment of localized non-Hodgkin's lymphoma in children: a report from the Children's Cancer Study GroupR D Jenkin, J R Anderson, R R Chilcote, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Cancer|December 15, 1980
Bone sarcoma as a second malignant neoplasm in children: influence of radiation and genetic predisposition for the Late Effects Study GroupA T Meadows, L C Strong, F P Li, et al.
The New England Journal of Medicine|March 10, 1983
Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)J R Anderson, J F Wilson, D T Jenkin, et al.
Medical and Pediatric Oncology|January 1, 1994
Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552J L Finlay, J R Anderson, A J Cecalupo, et al.
Medical and Pediatric Oncology|December 18, 2001
Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer GroupR Sposto, A T Meadows, R R Chilcote, et al.
Journal of Health Psychology|October 25, 2011
Pathways Linking Treatment Intensity and Psychosocial Outcomes among Adult Survivors of Childhood LeukemiaE Chen, L K Zeltzer, P M Bentler, et al.
Journal of the National Cancer Institute|March 1, 1987
Leukemia after therapy with alkylating agents for childhood cancerM A Tucker, A T Meadows, J D Boice, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912N L Kobrinsky, R Sposto, N R Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer GroupJ R Anderson, R D Jenkin, J F Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Childrens Cancer Study GroupA T Meadows, R Sposto, R D Jenkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1984
The treatment of localized non-Hodgkin's lymphoma in children: a report from the Children's Cancer Study GroupR D Jenkin, J R Anderson, R R Chilcote, et al.
Pageof 16